Defunct Company
Total Trials
9
As Lead Sponsor
As Collaborator
0
Total Enrollment
6,726
NCT00567346
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
Phase: Phase 2/3
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: Mar 31, 2008
NCT00824447
Long-term Efficacy and Safety Study With Oralgen Grass Pollen
Start: Aug 31, 2007
Completion: Jan 31, 2009
NCT00812799
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
Phase: Phase 3
Start: Dec 31, 2008
Completion: Dec 31, 2011
NCT00889889
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination
Phase: Phase 2
Start: May 31, 2009
Completion: Jan 31, 2011
NCT00881842
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season
Start: Jun 30, 2009
Completion: Jul 31, 2009
NCT01013675
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly
Start: Nov 30, 2009
Completion: Apr 30, 2011
NCT00999206
Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine
Start: Jan 31, 2010
Completion: Aug 31, 2010
NCT01146015
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season
Start: Jun 30, 2010
Completion: Jul 31, 2010
NCT01633749
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season
Start: Jul 31, 2012
Completion: Jul 31, 2012